APA (7th ed.) Citation

BT, H., WY, L., CL, Y., YT, T., K, P., PC, Y., & EP, L. (2024). AptBCis1, An Aptamer-Cisplatin Conjugate, Is Effective in Lung Cancer Leptomeningeal Carcinomatosis. ACS nano, 18(41), 27905. https://doi.org/10.1021/acsnano.4c04680

Chicago Style (17th ed.) Citation

BT, Huang, Lai WY, Yeh CL, Tseng YT, Peck K, Yang PC, and Lin EP. "AptBCis1, An Aptamer-Cisplatin Conjugate, Is Effective in Lung Cancer Leptomeningeal Carcinomatosis." ACS Nano 18, no. 41 (2024): 27905. https://doi.org/10.1021/acsnano.4c04680.

MLA (9th ed.) Citation

BT, Huang, et al. "AptBCis1, An Aptamer-Cisplatin Conjugate, Is Effective in Lung Cancer Leptomeningeal Carcinomatosis." ACS Nano, vol. 18, no. 41, 2024, p. 27905, https://doi.org/10.1021/acsnano.4c04680.